SOLIBER
ActiveSummary
SOLIBER has been active since 2009 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of €538,997. Equity is growing by ~11.2% per year across the filed fiscal years. Its solvency ranks better than 92% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability94▼-6
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €230,000 at 30 days acceptable
Liquidity ample (current ratio 19.23 against 25.62 in 2024; short-term debt: 3.1% and cash: 28.5% of total assets), and 4.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
95.6%
Return on assets
20.5%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-07-2026, 10 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
10 d early
2024
13 d early
2023
213 d late
2022
11 d late
2021
28 d late
2020
31 d late
2019
45 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 44 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€2.5m▲ 13.9%
2024 · €2.2m
Total assets
€2.6m▲ 14.8%
2024 · €2.3m
Net result
€538,997▼ 13.3%
2024 · €621,924
Working capital
€1.5m▲ 26.1%
2024 · €1.2m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€395,468▲ 4.6%€482,266▲ 21.9%€463,111▼ 4.0%€871,593▲ 88.2%€694,123▼ 20.4%
Net result€269,318above the sector's middle half▲ 4.1%€330,418above the sector's middle half▲ 22.7%€318,251above the sector's middle half▼ 3.7%€621,924above the sector's middle half▲ 95.4%€538,997above the sector's middle half▼ 13.3%
Equity€1.5mabove the sector's middle half▲ 5.4%€1.6mabove the sector's middle half▲ 5.9%€1.8mabove the sector's middle half▲ 10.0%€2.2mabove the sector's middle half▲ 25.6%€2.5mabove the sector's middle half▲ 13.9%
Total assets€1.6mabove the sector's middle half▲ 7.2%€1.7mabove the sector's middle half▲ 5.3%€1.8mabove the sector's middle half▲ 8.2%€2.3mabove the sector's middle half▲ 27.3%€2.6mabove the sector's middle half▲ 14.8%
Debt€70,433▲ 70.7%€65,614▼ 6.8%€42,827▼ 34.7%€47,895▲ 11.8%€81,537▲ 70.2%
Working capital€606,784above the sector's middle half▼ 3.0%€743,619above the sector's middle half▲ 22.6%€497,941above the sector's middle half▼ 33.0%€1.2mabove the sector's middle half▲ 137%€1.5mabove the sector's middle half▲ 26.1%
Solvency95.5%above the sector's middle half▼ 1.7pp96.1%above the sector's middle half▲ 0.5pp97.6%above the sector's middle half▲ 1.6pp96.3%above the sector's middle half▼ 1.3pp95.6%above the sector's middle half▼ 0.7pp
Current ratio9.62above the sector's middle half▼ 6.5512.33above the sector's middle half▲ 2.7212.63above the sector's middle half▲ 0.2925.62above the sector's middle half▲ 12.9919.23above the sector's middle half▼ 6.39
Return on assets (ROA)17.0%within the sector's middle half▼ 0.5pp19.8%within the sector's middle half▲ 2.8pp17.7%within the sector's middle half▼ 2.2pp27.1%within the sector's middle half▲ 9.4pp20.5%within the sector's middle half▼ 6.6pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 20% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.6m
Fixed assets
€1.1m ▼ 0.1%
Current assets
€1.6m ▲ 27.8%
Equity and liabilities €2.6m
Equity
€2.5m ▲ 13.9%
Provisions
€35,593 ▼ 4.9%
Debt
€81,537 ▲ 70.2%
Debt's share of the balance-sheet total rises from 2.1% to 3.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€757,090▼
2024 · €940,008
Cash flow
€601,964▼
2024 · €690,340
Debt to equity
0.03▲
2024 · 0.02
ROE
21.4%▼
2024 · 28.2%
Interest coverage
444.96▼
2024 · 6963.03
Debt ≤ 1 year
€81,537▲
2024 · €47,895
Income taxes
€193,227▼
2024 · €215,536
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,810 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
3.1%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,810 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €2,751 | €1,494 | - | €389 | €3,750 | ▲ 864% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €69,957 | €52,085 | €122,325 | €68,416 | €62,967 | ▼ 8.0% |
| Other operating charges640/8 | €10,820 | €10,234 | €13,488 | €17,063 | €17,049 | ▼ 0.1% |
| Gross operating margin9900 | €476,245 | €544,584 | €598,925 | €957,072 | €774,139 | ▼ 19.1% |
| Operating profit (loss)9901 | €395,468 | €482,266 | €463,111 | €871,593 | €694,123 | ▼ 20.4% |
| Financial income75/76B | €13,996 | - | €713 | €5,280 | €37,960 | ▲ 619% |
| Recurring financial income75 | €496 | - | €713 | €5,280 | €37,960 | ▲ 619% |
| Non-recurring financial income76B | €13,500 | - | - | - | - | - |
| Financial charges65/66B | €796 | €480 | €120 | €135 | €1,701 | ▲ 1,160% |
| Recurring financial charges65 | €796 | €480 | €120 | €135 | €1,701 | ▲ 1,160% |
| Profit (loss) for the period before taxes9903 | €408,668 | €481,786 | €463,704 | €876,737 | €730,381 | ▼ 16.7% |
| Transfer from deferred taxes780 | - | - | - | - | €1,842 | - |
| Transfer to deferred taxes680 | - | - | - | €39,278 | - | - |
| Income taxes67/77 | €139,349 | €151,368 | €145,453 | €215,536 | €193,227 | ▼ 10.4% |
| Profit (loss) for the period9904 | €269,318 | €330,418 | €318,251 | €621,924 | €538,997 | ▼ 13.3% |
| Transfer from tax-exempt reserves789 | €56,250 | - | - | €7,370 | €5,527 | ▼ 25.0% |
| Transfer to tax-exempt reserves689 | - | - | - | €277,814 | €126,300 | ▼ 54.5% |
| Profit (loss) for the period to be appropriated9905 | €325,568 | €330,418 | €318,251 | €351,479 | €418,224 | ▲ 19.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.6m | €1.7m | €1.8m | €2.3m | €2.6m | ▲ 14.8% |
| Fixed assets21/28 | €903,811 | €856,151 | €1.3m | €1.1m | €1.1m | ▼ 0.1% |
| Tangible fixed assets22/27 | €903,811 | €856,151 | €1.3m | €1.1m | €1.1m | ▼ 0.1% |
| Land and buildings22 | €854,175 | €816,597 | €1.2m | €1.0m | €977,562 | ▼ 4.5% |
| Plant, machinery and equipment23 | €12,432 | €11,442 | €9,783 | €14,797 | €15,379 | ▲ 3.9% |
| Furniture and vehicles24 | €37,203 | €28,112 | €18,870 | €19,358 | €63,945 | ▲ 230% |
| Other tangible fixed assets26 | - | - | - | €9,500 | €9,500 | = |
| Current assets29/58 | €677,217 | €809,233 | €540,768 | €1.2m | €1.6m | ▲ 27.8% |
| Amounts receivable within one year40/41 | €200,583 | €212,059 | €235,383 | €291,463 | €274,178 | ▼ 5.9% |
| Trade receivables40 | €200,583 | €212,059 | €234,288 | €291,215 | €273,930 | ▼ 5.9% |
| Other amounts receivable41 | - | - | €1,095 | €248 | €248 | = |
| Current investments50/53 | €396,611 | €496,137 | €275,744 | €34,424 | €540,511 | ▲ 1,470% |
| Cash at bank and in hand54/58 | €77,605 | €99,213 | €28,470 | €899,701 | €750,898 | ▼ 16.5% |
| Deferred charges and accrued income490/1 | €2,418 | €1,824 | €1,171 | €1,540 | €2,373 | ▲ 54.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.6m | €1.7m | €1.8m | €2.3m | €2.6m | ▲ 14.8% |
| Equity10/15 | €1.5m | €1.6m | €1.8m | €2.2m | €2.5m | ▲ 13.9% |
| Contributions10/11 | €6,200 | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €1.5m | €1.6m | €1.8m | €2.2m | €2.5m | ▲ 14.0% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Tax-exempt reserves132 | - | - | - | €272,287 | €393,059 | ▲ 44.4% |
| Distributable reserves133 | €1.5m | €1.6m | €1.8m | €1.9m | €2.1m | ▲ 9.7% |
| Provisions and deferred taxes16 | - | - | - | €37,436 | €35,593 | ▼ 4.9% |
| Deferred taxes168 | - | - | - | €37,436 | €35,593 | ▼ 4.9% |
| Amounts payable17/49 | €70,433 | €65,614 | €42,827 | €47,895 | €81,537 | ▲ 70.2% |
| Amounts payable within one year42/48 | €70,433 | €65,614 | €42,827 | €47,895 | €81,537 | ▲ 70.2% |
| Trade debts44 | €1,021 | €64 | €3,147 | €16,615 | €9,869 | ▼ 40.6% |
| Suppliers440/4 | €1,021 | €64 | €3,147 | €16,615 | €9,869 | ▼ 40.6% |
| Taxes, remuneration and social security45 | €63,343 | €59,052 | €39,681 | €26,366 | €67,050 | ▲ 154% |
| Taxes450/3 | €63,343 | €53,477 | €36,783 | €26,366 | €67,050 | ▲ 154% |
| Remuneration and social security454/9 | - | €5,575 | €2,898 | - | - | - |
| Other amounts payable47/48 | €6,068 | €6,497 | - | €4,913 | €4,618 | ▼ 6.0% |
| Accrued charges and deferred income492/3 | - | - | €0 | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €269,318 | €330,418 | €318,251 | €621,924 | €538,997 | ▼ 13.3% |
| + Depreciation and write-downs630 | €69,957 | €52,085 | €122,325 | €68,416 | €62,967 | ▼ 8.0% |
| Operating cash flow (approximation) | €339,276 | €382,502 | €440,576 | €690,340 | €601,964 | ▼ 12.8% |
| Investment in fixed assets (approximation) | - | -€4,425 | -€527,740 | €125,877 | -€62,081 | ▼ 149% |
| Change in cash | - | €21,608 | -€70,743 | €871,231 | -€148,803 | ▼ 117% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
21-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
18-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
01-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 213 days late
2024
31-12
Financial
Highest result since 2018net €621,924 ▲95.4%
Operating result €871,593, net result €621,924, both a record.
31-12
Financial
Liquidity doublescurrent ratio 25.62
Current ratio from 12.63 to 25.62.
31-12
Financial
Equity above €2mEq €2.2m ▲25.6%
7 profitable years in a row build equity to €2.2m.
2023
11-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 11 days late
2022
28-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 28 days late
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
14-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 45 days late
2019
19-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 19 days late
2018
16-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
24-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tournai
Ground area
2,072 m²
Building footprint
171 m²
Volume, LiDAR
971 m³
Parcel 57042C0666/00P002, Wallonia · tallest building 7.3 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 57042C0666/00P002 | Wallonia | 2,072 m² | 1 · 171 m² | 7.3 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
6488LH5U8TGU2730C033
Similar companies · same sector, comparable size
DR. HERMAN POLLENTIER
BE 0894.149.364
Jabbeke · Eq €2,525,270
Dokter Willy De Muyter
BE 0810.181.414
Sint-Truiden · Eq €2,509,089
Dokter Johan Orye
BE 0828.126.216
Hasselt · Eq €2,498,945
MAISON MEDICALE DE WATERMAEL - BOITSFORT - AUDERGHEM
BE 0850.868.954
Watermaal-Bosvoorde · Eq €2,535,775
DOKTER WITDOUCK - ALGEMENE GENEESKUNDE
BE 0456.820.114
Izegem · Eq €2,540,246
Of 9,128 companies in sector 86210 we hold annual accounts for 6,335. 2,542 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded17-03-2009
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0810472315
Registered
11-05-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.